Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kezar Life Sciences Inc (NQ: KZR ) 0.6642 +0.0092 (+1.40%) Streaming Delayed Price Updated: 3:15 PM EDT, Jul 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Kezar Life Sciences Inc < Previous 1 2 3 4 5 6 Next > Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at the American College of Rheumatology Convergence 2022 November 14, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) November 11, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update November 10, 2022 From Kezar Life Sciences, Inc. Via Business Wire Wells Fargo Beefs Up Kezar Life Price Target - Read Why June 28, 2022 Via Benzinga Kezar Life Sciences (KZR) Stock Soars on Lupus Trial Results June 28, 2022 KZR stock is soaring today on news that Kezar Life Sciences' Lupus treatment showed positive results in a clinical trial. Via InvestorPlace Kezar Life Sciences to Participate in Two Upcoming Investor Conferences November 09, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at ASN’s Kidney Week 2022 Annual Meeting November 03, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in Patients with Lupus Nephritis at the American Society of Nephrology’s Kidney Week 2022 Annual Meeting October 14, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 06, 2022 From Kezar Life Sciences, Inc. Via Business Wire Why Kezar Life Sciences Shares Are Volatile After Hours October 03, 2022 Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading higher in Monday's after-hours session after the company announced that it has received clearance of its Investigational New Drug (IND)... Via Benzinga Kezar Life Sciences Receives FDA Clearance of IND for Zetomipzomib for the Treatment of Autoimmune Hepatitis October 03, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in Patients with Lupus Nephritis at the American College of Rheumatology Convergence 2022 September 29, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) September 02, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Participate in Three Upcoming Investor Conferences September 01, 2022 From Kezar Life Science Via Business Wire Kezar Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update August 11, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) August 03, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Appoints Nick Mordwinkin as Chief Business Officer and Reports Updated Cash Position July 11, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Stock Shows Rising Market Leadership: Earns 81 RS Rating July 08, 2022 The Relative Strength (RS) Rating for Kezar Life Sciences stock jumped into a new percentile Friday, with a rise from 78 to 81. Via Investor's Business Daily Kezar Life Sciences to Present at the William Blair Biotech Focus Conference July 07, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) July 06, 2022 From Kezar Life Sciences, Inc. Via Business Wire The Week In Charts: How To Make Money While Waiting For Core Trend Trades July 02, 2022 The real money is in the longer-term core trend trades. However, sometimes those opportunities can be few and far between. This is especially true in a bear market. Via Talk Markets Biotech ETF Tops in June: 5 Stocks That Outperform June 30, 2022 Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%. Via Talk Markets Short Volatility Alert: Kezar Life Sciences, Inc. June 29, 2022 On Tuesday, shares of Kezar Life Sciences, Inc. (NASDAQ: KZR) experienced volatile short activity. After the activity, the stock price went up +43.43% to $8.29. The overall sentiment for KZR has been... Via Benzinga InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday June 29, 2022 Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. Via Benzinga Dow Dips Over 400 Points; Crude Oil Rises 2% June 28, 2022 U.S. stocks turned sharply lower toward the end of trading, with the Dow Jones dropping more than 400 points on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 28, 2022 Gainers Via Benzinga Nasdaq Turns Lower; Kezar Life Sciences Shares Jump June 28, 2022 U.S. stocks pared gains midway through trading, with the Nasdaq Composite and S&P 500 turning lower on Tuesday. Via Benzinga Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session June 28, 2022 Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. Via Benzinga Occidental Petroleum (OXY) Stock Gets Boost From Yet Another Buffett Buy June 28, 2022 Occidental Petroleum (OXY) stock is rising on Tuesday after Warren Buffett's Berkshire Hathaway increased its stake in the company. Via InvestorPlace Markets Open Higher; US Goods Gap Narrows To $104.3B In May June 28, 2022 U.S. stocks traded higher this morning, with the Dow Jones gaining over 350 points on Tuesday. Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.